Transient elastography improves detection of liver cirrhosis compared to routine screening tests

Liver cirrhosis remains a major cause of morbidity and mortality in chronic liver disease. Current diagnostic tools rely on a combination of clinical signs, laboratory tests, and imaging. However, these methods often fail to detect cirrhosis in its early stages. Prior research has shown that ultrasound and platelet count have limited sensitivity for cirrhosis. No prior work had resolved the comparative effectiveness of transient elastography in routine clinical settings. That uncertainty drove this study to evaluate how TE performs against existing methods. Clinical signs like jaundice or spider nevi are not consistently present in early cirrhosis. Laboratory parameters such as bilirubin or albumin are late indicators of liver damage. This gap motivated the need for a non-invasive test with higher sensitivity. Liver biopsy remains the gold standard but is invasive and not ideal for routine use. The study aimed to determine whether TE could serve as a more reliable alternative in daily practice.

The study aimed to evaluate the diagnostic accuracy of transient elastography in identifying liver cirrhosis in patients with chronic liver disease. Researchers compared TE to ultrasound, clinical signs, and lab tests in a real-world setting. The goal was to determine if TE could detect cirrhosis more effectively than existing methods. Patients with various causes of chronic liver disease were included in the study. All participants underwent liver biopsy as the reference standard. The researchers assessed the sensitivity of each diagnostic method. They also measured the area under the receiver operating characteristic curve for each test. The study focused on whether TE could improve detection rates in subgroups like Child Pugh A patients or those with normal platelet counts. The ultimate aim was to assess the clinical utility of TE in routine practice.

The study included 291 patients with chronic liver disease who had liver biopsies performed in daily clinical practice. Transient elastography was performed alongside ultrasound, laboratory tests, and physical examination. Researchers evaluated the presence of cutaneous liver signs such as spider nevi and palmar erythema. Platelet count, bilirubin, albumin, and prothrombin time were recorded for each patient. Sensitivity for cirrhosis detection was calculated for each diagnostic method. The area under the receiver operating characteristic curve was also determined. The study compared TE results to histological findings from liver biopsies. Researchers analyzed whether combining TE with ultrasound improved diagnostic accuracy. Statistical analyses included correlation coefficients and p-values for significance. The study focused on subgroups with normal platelet counts or Child Pugh A classification.

Transient elastography had a sensitivity of 90.4% for detecting liver cirrhosis. This was significantly higher than the 80.1% sensitivity of ultrasound. Platelet count had a sensitivity of 58.0%, and cutaneous signs had 45.1%. The area under the curve for TE was 0.760, with a 95% confidence interval of 0.694 to 0.825. Combining TE with ultrasound increased sensitivity to 96.1%. The combined method also improved the area under the curve to 0.825. TE correlated with albumin (r = -0.43), prothrombin time (r = -0.44), and bilirubin (r = 0.34). In Child Pugh A patients, TE improved sensitivity by 14.1% compared to ultrasound. In patients with normal platelet counts, the improvement was 16.3%. These results suggest that TE can detect cirrhosis in 10% to 16% more patients than existing methods.

The study found that transient elastography outperformed routine diagnostic tests for liver cirrhosis. TE detected cirrhosis in more patients than ultrasound, platelet count, or cutaneous signs. The combination of TE and ultrasound further improved diagnostic accuracy. The researchers propose that TE is a more reliable method in daily clinical practice. The results suggest that TE can identify cirrhosis in patients who would otherwise be missed. The study supports the use of TE as a non-invasive alternative to liver biopsy. The authors suggest that TE should be integrated into routine screening protocols. They propose that combining TE with ultrasound could enhance detection rates. The findings indicate that TE is particularly useful in patients with normal platelet counts. The study concludes that TE improves the sensitivity of cirrhosis detection in chronic liver disease.